Clovis Oncology Announces Pricing of Public Offerings of Convertible Senior Notes and Common Stock

World News: . []

Clovis Oncology Inc NASDAQCLVS announced today the upsizing and pricing of an underwritten public offering of 36300 million aggregate principal amount of its 125 convertible senior notes due 2025 at a price to t he publ...

More news and information about Clovis Oncology, Inc.

Published By:

Business Wire: 01:54 GMT Tuesday 17th April 2018

Published: .

Search for other references to "clovis" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us